The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017.
BACKGROUND:Ontario, Canada introduced a publicly-funded 13-valent pneumococcal conjugate vaccine (PCV13) for infants in 2010, replacing the 10-valent (PCV10, 2009-2010) and the 7-valent (PCV7, 2005-2009) conjugate vaccine programs; a 23-valent pneumococcal polysaccharide vaccine (PPV23) has been ava...
Main Authors: | Shinthuja Wijayasri, Kelty Hillier, Gillian H Lim, Tara M Harris, Sarah E Wilson, Shelley L Deeks |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0226353 |
Similar Items
-
The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013.
by: Shalini Desai, et al.
Published: (2015-01-01) -
Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010â2015
by: Vic Eton, et al.
Published: (2017-12-01) -
Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010
by: Dang Vica, et al.
Published: (2012-08-01) -
Epidemiology of invasive pneumococcal disease in indigenous and non-indigenous adults in northwestern Ontario, Canada, 2006–2015
by: Daniel Dalcin, et al.
Published: (2018-12-01) -
Characterization of culture-positive adenovirus serotypes from respiratory specimens in Toronto, Ontario, Canada: September 2007–June 2008
by: Mazzulli Tony, et al.
Published: (2009-01-01)